Edwards Lifesciences Gross Margin 2010-2024 | EW

Current and historical gross margin for Edwards Lifesciences (EW) over the last 10 years. The current gross profit margin for Edwards Lifesciences as of March 31, 2024 is %.
Edwards Lifesciences Gross Margin Historical Data
Date TTM Revenue TTM Gross Profit Gross Margin
2024-03-31 $6.14B $4.71B 76.64%
2023-12-31 $6.01B $4.63B 77.02%
2023-09-30 $5.82B $4.54B 77.99%
2023-06-30 $5.66B $4.47B 79.05%
2023-03-31 $5.50B $4.39B 79.80%
2022-12-31 $5.38B $4.30B 79.93%
2022-09-30 $5.36B $4.23B 78.90%
2022-06-30 $5.36B $4.17B 77.78%
2022-03-31 $5.36B $4.10B 76.57%
2021-12-31 $5.23B $3.98B 76.11%
2021-09-30 $5.10B $3.86B 75.72%
2021-06-30 $4.93B $3.72B 75.52%
2021-03-31 $4.48B $3.37B 75.20%
2020-12-31 $4.39B $3.31B 75.36%
2020-09-30 $4.37B $3.30B 75.51%
2020-06-30 $4.32B $3.24B 74.99%
2020-03-31 $4.48B $3.34B 74.42%
2019-12-31 $4.35B $3.23B 74.38%
2019-09-30 $4.15B $3.09B 74.40%
2019-06-30 $3.97B $2.97B 74.88%
2019-03-31 $3.82B $2.88B 75.46%
2018-12-31 $3.72B $2.78B 74.76%
2018-09-30 $3.64B $2.69B 74.11%
2018-06-30 $3.55B $2.62B 73.80%
2018-03-31 $3.45B $2.55B 74.04%
2017-12-31 $3.44B $2.56B 74.48%
2017-09-30 $3.32B $2.46B 74.22%
2017-06-30 $3.23B $2.39B 73.96%
2017-03-31 $3.15B $2.32B 73.56%
2016-12-31 $2.96B $2.17B 73.10%
2016-09-30 $2.87B $2.11B 73.52%
2016-06-30 $2.74B $2.04B 74.30%
2016-03-31 $2.60B $1.94B 74.55%
2015-12-31 $2.49B $1.88B 75.22%
2015-09-30 $2.44B $1.84B 75.34%
2015-06-30 $2.43B $1.81B 74.38%
2015-03-31 $2.39B $1.78B 74.27%
2014-12-31 $2.32B $1.70B 73.13%
2014-09-30 $2.24B $1.63B 72.86%
2014-06-30 $2.13B $1.56B 73.27%
2014-03-31 $2.07B $1.53B 73.88%
2013-12-31 $2.05B $1.53B 74.73%
2013-09-30 $2.02B $1.53B 75.50%
2013-06-30 $1.97B $1.49B 75.76%
2013-03-31 $1.94B $1.45B 74.96%
2012-12-31 $1.90B $1.41B 74.14%
2012-09-30 $1.82B $1.33B 73.17%
2012-06-30 $1.78B $1.28B 71.86%
2012-03-31 $1.73B $1.23B 71.15%
2011-12-31 $1.68B $1.19B 70.82%
2011-09-30 $1.64B $1.16B 70.51%
2011-06-30 $1.58B $1.12B 71.21%
2011-03-31 $1.51B $1.09B 71.81%
2010-12-31 $1.45B $1.04B 71.80%
2010-09-30 $1.40B $1.01B 71.68%
2010-06-30 $1.38B $0.98B 70.99%
2010-03-31 $1.35B $0.95B 70.22%
2009-12-31 $1.32B $0.92B 69.77%
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $54.831B $6.005B
Edwards Lifesciences Corporation deals in products and technologies aimed at treating advanced cardiovascular diseases, especially structural heart disease in critically ill patients. The company is the world's leading manufacturer of tissue heart valves and repair products used to replace or repair a patient's diseased or defective heart valve. Edwards is also a leading player in hemodynamic monitoring systems used to measure a patient's cardiovascular function in the hospital setting. The company's products and technologies are categorized into four main areas: Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral and Tricuspid Therapies (TMTT), Surgical Structural Heart, and Critical Care.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $209.215B 25.35
Intuitive Surgical (ISRG) United States $157.544B 94.91
DexCom (DXCM) United States $45.360B 68.71
Alcon (ALC) Switzerland $45.237B 32.42
IQVIA Holdings (IQV) United States $40.844B 23.70
IDEXX Laboratories (IDXX) United States $40.694B 47.70
STERIS (STE) Ireland $21.918B 25.60
SONOVA HOLDING (SONVY) Switzerland $18.440B 0.00
Hologic (HOLX) United States $18.131B 20.28
Waters (WAT) United States $17.938B 26.36
Fresenius Medical Care AG KGaA (FMS) Germany $11.684B 13.64
Teleflex (TFX) United States $10.385B 16.16
Sysmex ADR (SSMXY) Japan $10.297B 32.29
Globus Medical (GMED) United States $9.621B 28.20
Penumbra (PEN) United States $7.398B 84.07
Glaukos (GKOS) United States $6.099B 0.00
Masimo (MASI) United States $5.954B 34.24
TransMedics (TMDX) United States $4.683B 444.34
Integer Holdings (ITGR) United States $4.028B 24.34
PROCEPT BioRobotics (PRCT) United States $3.566B 0.00
Inari Medical (NARI) United States $3.163B 0.00
Tandem Diabetes Care (TNDM) United States $2.976B 0.00
LivaNova (LIVN) United Kingdom $2.785B 16.54
Integra LifeSciences Holdings (IART) United States $2.365B 10.31
RxSight (RXST) United States $1.765B 0.00
Veracyte (VCYT) United States $1.739B 0.00
Alphatec Holdings (ATEC) United States $1.574B 0.00
Artivion (AORT) United States $1.138B 109.12
Silk Road Medical (SILK) United States $1.069B 0.00
Pulse Biosciences (PLSE) United States $1.026B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.968B 18.82
OPKO Health (OPK) United States $0.962B 0.00
OrthoPediatrics (KIDS) United States $0.780B 0.00
SiBone (SIBN) United States $0.631B 0.00
Paragon 28 (FNA) United States $0.629B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.592B 0.00
IRadimed (IRMD) United States $0.574B 32.17
Mesa Laboratories (MLAB) United States $0.571B 16.88
Treace Medical Concepts (TMCI) United States $0.504B 0.00
Pacific Biosciences Of California (PACB) United States $0.458B 0.00
Sight Sciences (SGHT) United States $0.379B 0.00
AxoGen (AXGN) United States $0.361B 0.00
Nevro (NVRO) United States $0.337B 0.00
Tactile Systems Technology (TCMD) United States $0.286B 9.77
AngioDynamics (ANGO) United States $0.240B 0.00
Semler Scientific (SMLR) United States $0.237B 12.01
Delcath Systems (DCTH) United States $0.224B 0.00
NeuroPace (NPCE) United States $0.214B 0.00
Inogen (INGN) United States $0.212B 0.00
CVRx (CVRX) United States $0.210B 0.00
ClearPoint Neuro (CLPT) United States $0.206B 0.00
Accuray (ARAY) United States $0.196B 0.00
EDAP TMS S.A (EDAP) France $0.183B 0.00
908 Devices (MASS) United States $0.183B 0.00
Atossa Genetics (ATOS) United States $0.165B 0.00
Alpha Tau Medical (DRTS) Israel $0.155B 0.00
KORU Medical Systems (KRMD) United States $0.121B 0.00
Spectral Diagnostics (EDTXF) Canada $0.102B 0.00
Sensus Healthcare (SRTS) United States $0.101B 21.28
EnVVeno Medical (NVNO) United States $0.080B 0.00
Hyperfine (HYPR) United States $0.076B 0.00
Monogram Orthopaedics (MGRM) United States $0.072B 0.00
InspireMD (NSPR) Israel $0.061B 0.00
SEP Acquisition (SEPA) United States $0.059B 0.00
Neuronetics (STIM) United States $0.056B 0.00
LENSAR (LNSR) United States $0.056B 0.00
Vicarious Surgical (RBOT) United States $0.051B 0.00
T2 Biosystems (TTOO) United States $0.048B 0.00
Envoy Medical (COCH) United States $0.047B 0.00
Lucid Diagnostics (LUCD) United States $0.045B 0.00
DarioHealth (DRIO) United States $0.043B 0.00
Precision Optics (POCI) United States $0.038B 0.00
ReWalk Robotics (LFWD) Israel $0.033B 0.00
Spectral AI (MDAI) United States $0.033B 0.00
Rapid Micro Biosystems (RPID) United States $0.029B 0.00
Accelerate Diagnostics (AXDX) United States $0.025B 0.00
Pixie Dust Technologies (PXDT) Japan $0.023B 0.00
Ekso Bionics Holdings (EKSO) United States $0.022B 0.00
Aspira Women's Health (AWH) United States $0.020B 0.00
Microbot Medical (MBOT) United States $0.017B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.016B 0.00
QT Imaging Holdings (QTI) United States $0.015B 0.00
NexGel (NXGL) United States $0.013B 0.00
Check-Cap (CHEK) Israel $0.012B 0.00
Autonomix Medical (AMIX) United States $0.012B 0.00
PAVmed (PAVM) United States $0.008B 0.00
ENDRA Life Sciences (NDRA) United States $0.007B 0.00
Venus Concept (VERO) Canada $0.004B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.003B 0.00
Tenon Medical (TNON) United States $0.003B 0.00
Avinger (AVGR) United States $0.003B 0.00
ReShape Lifesciences (RSLS) United States $0.003B 0.00
Helius Medical Technologies (HSDT) United States $0.003B 0.00
Nuwellis (NUWE) United States $0.002B 0.00
Nanovibronix (NAOV) United States $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.000B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00